Neuberger Berman Group
PBYI icon

Neuberger Berman Group’s Puma Biotechnology PBYI Stock Holding History

Neuberger Berman Group’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,000
Closed -$296K – 1680
2018
Q2 		$296K Buy
+5,000
New +$290K ﹤0.01% 1523
2018
Q1 		– Sell
-2,400
Closed -$237K – 1727
2017
Q4 		$237K Sell
2,400
-4,100
-63% -$459K ﹤0.01% 1638
2017
Q3 		$778K Sell
6,500
-10,700
-62% -$995K ﹤0.01% 1208
2017
Q2 		$1.5M Buy
+17,200
New +$962K ﹤0.01% 1064
2015
Q2 		– Sell
-63,000
Closed -$14.9M – 1598
2015
Q1 		$14.9M Sell
63,000
-64
-0.1% -$13.7K 0.02% 762
2014
Q4 		$11.9M Sell
63,064
-3,600
-5% -$799K 0.01% 791
2014
Q3 		$15.9M Buy
+66,664
New +$13.7M 0.02% 736

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return